Otsuka Holdings Co Ltd -Otsuka Applies For Additional Indication Of Adjunctive Treatment Of Major Depressive Disorder For Rexulti (Brexpiprazole) In Japan

Jan 30 (Reuters) - Otsuka Holdings Co Ltd: * OTSUKA HOLDINGS CO LTD: OTSUKA APPLIES FOR ADDITIONAL INDICATION OF ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER FOR REXULTI (BREXPIPRAZOLE) IN JAPAN

Polypeptide Group CEO Resigns

Jan 30 (Reuters) - POLYPEPTIDE GROUP AG: * CEO OF POLYPEPTIDE RESIGNS * POLYPEPTIDE GROUP, A FOCUSED GLOBAL CDMO FOR PEPTIDE- AND OLIGONUCLEOTIDE-BASED ACTIVE PHARMACEUTICAL INGREDIENTS, TODAY

Under-funded WHO seeks 'reinforced' role in global health at key meeting

* WHO's executive board meets from Jan. 30-Feb. 7 * WHO seeking $6.86 bln for 2024-2025 budget * Body seen pushing for bigger role in global health crises By Jennifer Rigby and Emma Farge GENEVA, Jan

MEDIA-Slovenia's Krka eyeing promoter stake in India's Unichem - ET

- Source link: (https://bityl.co/Gtyq) - Note: Reuters has not verified this story and does not vouch for its accuracy (Bengaluru newsroom)

Ryman Healthcare Saw "Limited Impact" From New Zealand Floods - Spokesperson

Jan 30 (Reuters) - Ryman Healthcare Ltd spokesperson: * SEEN "LIMITED IMPACT TO OUR OPERATIONS" FROM NEW ZEALAND FLOODS Further company coverage:

Genetic Signatures Says Quarterly Sales Down 12% From Preceding Quarter

Jan 30 (Reuters) - Genetic Signatures Ltd: * QUARTERLY SALES OF A$4.7 MILLION; DOWN 12% FROM PRECEDING QUARTER Source text for Eikon: Further company coverage:

Saintmed Says Signed Contract For Sleep Test Service

Jan 30 (Reuters) - Saintmed PCL: * SIGNED CONTRACT FOR SLEEP TEST SERVICE AT FACULTY OF MEDICINE RAMATHIBODI HOSPITAL * CONTRACT FOR 26.9 MILLION BAHT Source text for Eikon: Further company coverage:

Rhinomed Reports 1H Unaudited Recognised Revenue Of A$3.4 Mln

Jan 30 (Reuters) - Rhinomed Ltd: * 1H FY23 UNAUDITED RECOGNISED REVENUE OF A$3.4M Source text for Eikon: Further company coverage:

Apiam Animal Health Announces Acquisition Of Two Mixed Animal Veterinary Businesses

Jan 30 (Reuters) - Apiam Animal Health Ltd: * ACQUISITION OF TWO MIXED ANIMAL VETERINARY BUSINESSES * DEAL FOR A$11.2 MILLION * CONTINUE ACCELERATED GROWTH PLANS TO INCREASE PRO-FORMA REVENUES TO A

Somnomed Posts Q2 Fy23 Revenue Of A$21.4 Million

Jan 30 (Reuters) - Somnomed Ltd: * Q2 FY23 REVENUE OF A$21.4 MILLION, UP 16.6% VERSUS PREVIOUS CORRESPONDING PERIOD * SEES FY23 REVENUE GROWTH GUIDANCE HAS BEEN REVISED TO BETWEEN 15-20% * SEES FY23